221 related articles for article (PubMed ID: 31097476)
1. HDAC3 Deficiency Promotes Liver Cancer through a Defect in H3K9ac/H3K9me3 Transition.
Ji H; Zhou Y; Zhuang X; Zhu Y; Wu Z; Lu Y; Li S; Zeng Y; Lu QR; Huo Y; Shi Y; Bu H
Cancer Res; 2019 Jul; 79(14):3676-3688. PubMed ID: 31097476
[TBL] [Abstract][Full Text] [Related]
2. Histone deacetylase 3 promotes liver regeneration and liver cancer cells proliferation through signal transducer and activator of transcription 3 signaling pathway.
Lu XF; Cao XY; Zhu YJ; Wu ZR; Zhuang X; Shao MY; Xu Q; Zhou YJ; Ji HJ; Lu QR; Shi YJ; Zeng Y; Bu H
Cell Death Dis; 2018 Mar; 9(3):398. PubMed ID: 29540666
[TBL] [Abstract][Full Text] [Related]
3. Hdac3 is essential for the maintenance of chromatin structure and genome stability.
Bhaskara S; Knutson SK; Jiang G; Chandrasekharan MB; Wilson AJ; Zheng S; Yenamandra A; Locke K; Yuan JL; Bonine-Summers AR; Wells CE; Kaiser JF; Washington MK; Zhao Z; Wagner FF; Sun ZW; Xia F; Holson EB; Khabele D; Hiebert SW
Cancer Cell; 2010 Nov; 18(5):436-47. PubMed ID: 21075309
[TBL] [Abstract][Full Text] [Related]
4. Tumor Necrosis Factor Receptor-Associated Factor 6 Promotes Hepatocarcinogenesis by Interacting With Histone Deacetylase 3 to Enhance c-Myc Gene Expression and Protein Stability.
Wu H; Yang TY; Li Y; Ye WL; Liu F; He XS; Wang JR; Gan WJ; Li XM; Zhang S; Zhao YY; Li JM
Hepatology; 2020 Jan; 71(1):148-163. PubMed ID: 31155734
[TBL] [Abstract][Full Text] [Related]
5. Histone methyltransferase G9a promotes liver cancer development by epigenetic silencing of tumor suppressor gene RARRES3.
Wei L; Chiu DK; Tsang FH; Law CT; Cheng CL; Au SL; Lee JM; Wong CC; Ng IO; Wong CM
J Hepatol; 2017 Oct; 67(4):758-769. PubMed ID: 28532996
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic inactivation of the tumor suppressor gene RIZ1 in hepatocellular carcinoma involves both DNA methylation and histone modifications.
Zhang C; Li H; Wang Y; Liu W; Zhang Q; Zhang T; Zhang X; Han B; Zhou G
J Hepatol; 2010 Nov; 53(5):889-95. PubMed ID: 20675009
[TBL] [Abstract][Full Text] [Related]
7. Deletion of histone deacetylase 3 reveals critical roles in S phase progression and DNA damage control.
Bhaskara S; Chyla BJ; Amann JM; Knutson SK; Cortez D; Sun ZW; Hiebert SW
Mol Cell; 2008 Apr; 30(1):61-72. PubMed ID: 18406327
[TBL] [Abstract][Full Text] [Related]
8. Promyelocytic leukaemia protein links DNA damage response and repair to hepatitis B virus-related hepatocarcinogenesis.
Chung YL; Wu ML
J Pathol; 2013 Aug; 230(4):377-87. PubMed ID: 23620081
[TBL] [Abstract][Full Text] [Related]
9. Unmasking the pathological and therapeutic potential of histone deacetylases for liver cancer.
Zhao J; Gray SG; Greene CM; Lawless MW
Expert Rev Gastroenterol Hepatol; 2019 Mar; 13(3):247-256. PubMed ID: 30791763
[TBL] [Abstract][Full Text] [Related]
10. Histone deacetylases activate hepatocyte growth factor signaling by repressing microRNA-449 in hepatocellular carcinoma cells.
Buurman R; Gürlevik E; Schäffer V; Eilers M; Sandbothe M; Kreipe H; Wilkens L; Schlegelberger B; Kühnel F; Skawran B
Gastroenterology; 2012 Sep; 143(3):811-820.e15. PubMed ID: 22641068
[TBL] [Abstract][Full Text] [Related]
11. Expression of microRNA-195 is transactivated by Sp1 but inhibited by histone deacetylase 3 in hepatocellular carcinoma cells.
Zhao N; Li S; Wang R; Xiao M; Meng Y; Zeng C; Fang JH; Yang J; Zhuang SM
Biochim Biophys Acta; 2016 Jul; 1859(7):933-42. PubMed ID: 27179445
[TBL] [Abstract][Full Text] [Related]
12. Histone lysine methyltransferase SUV39H1 is a potent target for epigenetic therapy of hepatocellular carcinoma.
Chiba T; Saito T; Yuki K; Zen Y; Koide S; Kanogawa N; Motoyama T; Ogasawara S; Suzuki E; Ooka Y; Tawada A; Otsuka M; Miyazaki M; Iwama A; Yokosuka O
Int J Cancer; 2015 Jan; 136(2):289-98. PubMed ID: 24844570
[TBL] [Abstract][Full Text] [Related]
13. Impact of histone demethylase KDM3A-dependent AP-1 transactivity on hepatotumorigenesis induced by PI3K activation.
Nakatsuka T; Tateishi K; Kudo Y; Yamamoto K; Nakagawa H; Fujiwara H; Takahashi R; Miyabayashi K; Asaoka Y; Tanaka Y; Ijichi H; Hirata Y; Otsuka M; Kato M; Sakai J; Tachibana M; Aburatani H; Shinkai Y; Koike K
Oncogene; 2017 Nov; 36(45):6262-6271. PubMed ID: 28692045
[TBL] [Abstract][Full Text] [Related]
14. HDAC inhibition activates the apoptosome via Apaf1 upregulation in hepatocellular carcinoma.
Buurman R; Sandbothe M; Schlegelberger B; Skawran B
Eur J Med Res; 2016 Jun; 21(1):26. PubMed ID: 27342975
[TBL] [Abstract][Full Text] [Related]
15. Ataxin-3 represses transcription via chromatin binding, interaction with histone deacetylase 3, and histone deacetylation.
Evert BO; Araujo J; Vieira-Saecker AM; de Vos RA; Harendza S; Klockgether T; Wüllner U
J Neurosci; 2006 Nov; 26(44):11474-86. PubMed ID: 17079677
[TBL] [Abstract][Full Text] [Related]
16. Histone deacetylase 3 participates in self-renewal of liver cancer stem cells through histone modification.
Liu C; Liu L; Shan J; Shen J; Xu Y; Zhang Q; Yang Z; Wu L; Xia F; Bie P; Cui Y; Zhang X; Bian X; Qian C
Cancer Lett; 2013 Oct; 339(1):60-9. PubMed ID: 23879963
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B virus X protein induces the histone H3 lysine 9 trimethylation on the promoter of p16 gene in hepatocarcinogenesis.
Wang DY; Zou LP; Liu XJ; Zhu HG; Zhu R
Exp Mol Pathol; 2015 Dec; 99(3):399-408. PubMed ID: 26341139
[TBL] [Abstract][Full Text] [Related]
18. Histone deacetylase inhibitors promote ATP2A3 gene expression in hepatocellular carcinoma cells: p300 as a transcriptional regulator.
Hernández-Oliveras A; Izquierdo-Torres E; Meneses-Morales I; Rodríguez G; Zarain-Herzberg Á; Santiago-García J
Int J Biochem Cell Biol; 2019 Aug; 113():8-16. PubMed ID: 31146004
[TBL] [Abstract][Full Text] [Related]
19. Histone Deacetylase 3 Coordinates Deacetylase-independent Epigenetic Silencing of Transforming Growth Factor-β1 (TGF-β1) to Orchestrate Second Heart Field Development.
Lewandowski SL; Janardhan HP; Trivedi CM
J Biol Chem; 2015 Nov; 290(45):27067-27089. PubMed ID: 26420484
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis B virus X protein influences enrichment profiles of H3K9me3 on promoter regions in human hepatoma cell lines.
Wang DY; An SH; Liu L; Bai SS; Wu KX; Zhu R; Wang ZJ
Oncotarget; 2016 Dec; 7(51):84883-84892. PubMed ID: 27768594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
